Greatbatch files Form 10 for Nuvectra spin-off

• Greatbatch (GB -1.4%) files a Form 10 with the SEC for its proposed tax-free spin-off of its neuromodulation subsidiary QiG Group LLC, which will operate as Nuvectra Corp. Scott Drees will be the CEO. The spin-off should be completed by the end of the year.
• Nuvectra will focus on developing products for spinal cord stimulation, sacral nerve stimulation and deep brain stimulation.
• Management will host a conference call today at 5:00 pm ET to discuss the spin-off and Q2 results.